ENV-294 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Enveda Therapeutics60 enrolled17 locationsNCT07298395
Recruiting
Phase 2
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Asthma
Enveda Therapeutics50 enrolled14 locationsNCT07301255